Neoview
Payments companies reported to CMS as associated with Neoview. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neoview, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neoview
These are the largest totals companies reported as associated with Neoview. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amr El-Shafei | Rogers, AR | Cardiovascular Disease | $633.70 |
| Jose Iturbe | Dallas, TX | Interventional Cardiology | $244.00 |
| Nandish Thukral | San Antonio, TX | Interventional Cardiology | $158.15 |
| Travis Taylor | Corpus Christi, TX | Cardiovascular Disease | $60.66 |
| Gregg Silverman | Corpus Christi, TX | Cardiovascular Disease | $60.65 |
| John Canales | Live Oak, TX | Interventional Cardiology | $60.49 |
| Julie Camp | Independence, MO | Adult Health (Nurse Practitioner) | $14.08 |
| Alec Weisberg | Kansas City, MO | Cardiovascular Disease | $14.08 |
| Cesar Rios | Kansas City, MO | Cardiovascular Disease | $14.08 |
| James Marcum | Overland Park, KS | Cardiovascular Disease | $14.08 |
Prescribed Neoview?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.